Ratings by JPMorgan (Allen Gong)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/29/2024 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2024 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2023 | Glaukos Corporation | GKOS | Upgrade | Overweight (Neutral) |
81.24 (100.11) |
23.23% | Details | |
| 11/14/2023 | The Beauty Health Company | SKIN | Downgrade | Underweight (Neutral) |
3.60 (3.06) |
-15% | Details | |
| 11/6/2023 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/31/2023 | Establishment Labs Inc. | ESTA | New Coverage | Overweight (N/A) |
57.51 (48.54) |
-15.6% | Details | |
| 8/3/2023 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/26/2023 | The Beauty Health Company | SKIN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | The Beauty Health Company | SKIN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2023 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/22/2023 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | The Beauty Health Company | SKIN | Downgrade | Neutral (Overweight) |
11.30 (3.06) |
-72.92% | Details | |
| 11/4/2022 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2022 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2022 | TransMedics Group | TMDX | Upgrade | Overweight (Neutral) |
40.38 (89.25) |
121.03% | Details | |
| 3/11/2022 | The Beauty Health Company | SKIN | New Coverage | Overweight (N/A) |
18.29 (3.06) |
-83.27% | Details | |
| 12/17/2021 | TransMedics Group | TMDX | Maintain | (Neutral) |
|
Details | ||
| 12/17/2021 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details |
